Potentiation of NF-κB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells

British Journal of Pharmacology

Volumn 152, Issue 6, 2007, Pages 891-902

  Holden, N S ^a   Gong, W ^a   King, E M ^a   Kaur, M ^a   Giembycz, M A ^a   Newton, R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

BEAS 2B epithelial cells; Glucocorticoid; Histamine; IL 6; IL 8; Inflammation; Mepyramine; NF B

Indexed keywords

DEXAMETHASONE; HISTAMINE; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; AUTACOID; HISTAMINE RECEPTOR; I KAPPA B;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADENOVIRUS; BIOSYNTHESIS; BRONCHUS; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECT; GENE VECTOR; GENETICS; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

ADENOVIRIDAE; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; BRONCHI; CELL LINE; CELLS, CULTURED; DEXAMETHASONE; EPITHELIAL CELLS; GENE EXPRESSION; GENETIC VECTORS; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; RECEPTORS, HISTAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36048955411     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707457     Document Type: Article

References (59)

1. Akdis CA, Simons FE (2006). Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 533: 69-76.
2. Akira S, Kishimoto T (1997). NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol 65: 1-46.
3. Alexander SP, Mathie A, Peters JA (2006). Guide to receptors and channels, 2nd edition. Br J Pharmacol 147 (Suppl 3): S1-S168.
4. Armenante F, Merola M, Furia A, Tovey M, Palmieri M (1999). Interleukin-6 repression is associated with a distinctive chromatin structure of the gene. Nucleic Acids Res 27: 4483-4490.
5. Barnes PJ, Karin M (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071.
6. Bergmann M, Barnes PJ, Newton R (2000). Molecular regulation of granulocyte macrophage colony-stimulating factor in human lung epithelial cells by interleukin (IL)-1beta, IL-4, and IL-13 involves both transcriptional and post-transcriptional mechanisms. Am J Respir Cell Mol Biol 22: 582-589.
7. Bruysters M, Pertz HH, Teunissen A, Bakker RA, Gillard M, Chatelain P et al. (2004). Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens. Eur J Pharmacol 487: 55-63.
8. Catley MC, Cambridge LM, Nasuhara Y, Ito K, Chivers JE, Beaton A et al. (2004). Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding. J Biol Chem 279: 18457-18466.
9. Catley MC, Chivers JE, Holden NS, Barnes PJ, Newton R (2005). Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells. Br J Pharmacol 145: 114-122.
10. Chung KF (2006). Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets 7: 675-681.
11. Coge F, Guenin SP, Rique H, Boutin JA, Galizzi JP (2001). Structure and expression of the human histamine H4-receptor gene. Biochem Biophys Res Commun 284: 301-309.
12. Dale HH, Laidlaw PP (1911). Further observations on the action of beta-iminazolylethylamine. J Physiol 43: 182-195.
13. Davies DE, Holgate ST (2002). Asthma: the importance of epithelial mesenchymal communication in pathogenesis. Inflammation and the airway epithelium in asthma. Int J Biochem Cell Biol 34: 1520-1526.
14. Dendorfer U, Oettgen P, Libermann TA (1994). Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 14: 4443-4454.
15. Djuric DM, Andjelkovic IZ (1995). The evidence for histamine H3 receptor-mediated endothelium-dependent relaxation in isolated rat aorta. Mediators Inflamm 4: 217-221.
16. Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL (2006). The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 176: 7062-7070.
17. Faggioli L, Merola M, Hiscott J, Furia A, Monese R, Tovey M et al. (1997). Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma. Eur J Immunol 27: 3022-3030.
18. Flamand N, Plante H, Picard S, Laviolette M, Borgeat P (2004). Histamine-induced inhibition of leukotriene biosynthesis in human neutrophils: involvement of the H2 receptor and cAMP. Br J Pharmacol 141: 552-561.
19. Giovannini MG, Efoudebe M, Passani MB, Baldi E, Bucherelli C, Giachi F et al. (2003). Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells. J Neurosci 23: 9016-9023.
20. Impicciatore M, Morini G, Chiavarini M, Barocelli E, Bordi F, Plazzi PV et al. (1987). Are histamine receptors involved in the stimulant activities of thiazolylethylamines supposed as cyclic models of dimaprit? Agents Actions 20: 262-264.
21. Isshiki H, Akira S, Tanabe O, Nakajima T, Shimamoto T, Hirano T et al. (1990). Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol Cell Biol 10: 2757-2764.
22. Jeffery PK, Haahtela T (2006). Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 6 (Suppl 1): S5.
23. Jin S, Tian D, Chen JG, Zhu LP, Liu SY, Wang DX (2006). Passive sensitization increases histamine-stimulated calcium signaling and NF-kappaB transcription activity in bronchial epithelial cells. Acta Pharmacol Sin 27: 708-714.
24. Jutel M, Blaser K, Akdis CA (2005). Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol 137: 82-92.
25. Kamei C, Chung YH, Tasaka K (1990). Influence of certain H1-blockers on the step-through active avoidance response in rats. Psychopharmacology (Berl) 102: 312-318.
26. Kang SH, Brown DA, Kitajima I, Xu X, Heidenreich O, Gryaznov S et al. (1996). Binding and functional effects of transcriptional factor Sp1 on the murine interleukin-6 promotor. J Biol Chem 271: 7330-7335.
27. Karin M, Ben-Neriah Y (2000). Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663.
28. Krappmann D, Wulczyn FG, Scheidereit C (1996). Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J 15: 6716-6726.
29. Lew MJ, Angus JA (1995). Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol Sci 16: 328-337.
30. Li H, Choe NH, Wright DT, Adler KB (1995). Histamine provokes turnover of inositol phospholipids in guinea pig and human airway epithelial cells via an H1-receptor/G protein-dependent mechanism. Am J Respir Cell Mol Biol 12: 416-424.
31. Li Y, Chi L, Stechschulte DJ, Dileepan KN (2001). Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha. Microvasc Res 61: 253-262.
32. Libermann TA, Baltimore D (1990). Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10: 2327-2334.
33. Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005). Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314: 1310-1321.
34. Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L et al. (2004). Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 142: 161-171.
35. Liu WS, Heckman CA (1998). The sevenfold way of PKC regulation. Cell Signal 10: 529-542.
36. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A et al. (1999). Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55: 1101-1107.
37. Marone G, Granata F, Spadaro G, Genovese A, Triggiani M (2003). The histamine-cytokine network in allergic inflammation. J Allergy Clin Immunol 112: S83-S88.
38. 2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades. Biochem Pharmacol 69: 433-449.
39. McLeod RL, Aslanian R, del Prado M, Duffy R, Egan RW, Kreutner W et al. (1998). Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig. J Pharmacol Exp Ther 287: 43-50.
40. Meja KK, Catley MC, Cambridge LM, Barnes PJ, Lum H, Newton R et al. (2004). Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther 309: 833-844.
41. Milligan G (2004). G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66: 1-7.
42. Mills PR, Davies RJ, Devalia JL (1999). Airway epithelial cells, cytokines, and pollutants. Am J Respir Crit Care Med 160: S38-S43.
43. Morse KL, Behan J, Laz TM, West Jr RE, Greenfeder SA, Anthes JC et al. (2001). Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296: 1058-1066.
44. Motulsky H, Christopoulos A (2005). Fitting Models to Biological Data using Linear and Nonlinear Regression: a Practical Guide to Curve Fitting. GraphPad Software: San Diego.
45. Muller T, Myrtek D, Bayer H, Sorichter S, Schneider K, Zissel G et al. (2006). Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int J Mol Med 18: 925-931.
46. Newton R, Holden NS, Catley MC, Oyelusi W, Leigh R, Proud D et al. (2007). Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors. J Pharmacol Exp Ther 321: 734-742.
47. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ (1997). Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 237: 28-32.
48. O'Reilly M, Alpert R, Jenkinson S, Gladue RP, Foo S, Trim S et al. (2002). Identification of a histamine H4 receptor on human eosinophils - role in eosinophil chemotaxis. J Recept Signal Transduct Res 22: 431-448.
49. Ohkubo T, Shibata M, Inoue M, Kaya H, Takahashi H (1995). Regulation of substance P release mediated via prejunctional histamine H3 receptors. Eur J Pharmacol 273: 83-88.
50. Pahl HL (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
51. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT et al. (1988). Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48: 1904-1909.
52. Rouleau A, Stark H, Schunack W, Schwartz JC (2000). Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug. J Pharmacol Exp Ther 295: 219-225.
53. Talreja J, Kabir MH, B Filla M, Stechschulte DJ, Dileepan KN (2004). Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology 113: 224-233.
54. Tayo FM, Bevan JA (1986). Pharmacological characterization of histamine receptors in the rabbit renal artery. Eur J Pharmacol 121: 129-133.
55. 2+ signalling and membrane-potential oscillations in human HeLa carcinoma cells. Biochem J 266: 235-243.
56. Waud DR, Son SL, Waud BE (1978). Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example. Life Sci 22: 1275-1285.
57. Wellendorph P, Goodman MW, Burstein ES, Nash NR, Brann MR, Weiner DM (2002). Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H(3) receptor. Neuropharmacology 42: 929-940.
58. Wu RL, Anthes JC, Kreutner W, Harris AG, West Jr RE (2004). Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor. Int Arch Allergy Immunol 135: 313-318.
59. Zhang M, Thurmond RL, Dunford PJ (2006). The histamine H(4) receptor: a novel modulator of inflammatory and immune disorders. Pharmacol Ther 113: 594-606.